Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001144204-13-066773)

Filing Details

Accession Number:
0001144204-13-066773
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-12-11 17:37:58
Reporting Period:
2013-12-10
Filing Date:
2013-12-11
Accepted Time:
2013-12-11 17:37:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1077183 Neogenomics Inc NEO Services-Testing Laboratories (8734) 742897368
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1518647 P Robert Gasparini C/O Neogenomics, Inc.
12701 Commonwealth Drive Suite 9
Fort Myers FL US 33913		 Chief Science Officer No Yes No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-12-10 100 $3.70 44,758 No 4 S Direct
Common Stock Disposition 2013-12-11 20,000 $3.70 24,758 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Derivative Holdings
Show Other Fields >>
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (Right to buy) $0.25 2005-01-03 2015-01-03 0 425,000 Direct
Common Stock Stock Option (Right to buy) $1.47 2007-02-13 2017-02-13 0 100,000 Direct
Common Stock Stock Option (Right to buy) $0.80 2008-03-12 2015-03-12 0 584,000 Direct
Common Stock Stock Option Right to Buy) $0.62 2009-12-31 2016-02-01 0 150,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2015-01-03 0 425,000 Direct
2017-02-13 0 100,000 Direct
2015-03-12 0 584,000 Direct
2016-02-01 0 150,000 Direct
Footnotes
  1. On March 12, 2008 Mr. Gasparini was granted an option to purchase 784,000 shares. The first vesting and exercisable date was March 12, 2008. On this date 24,000 options vested and then there was to be 45 additional monthly vesting of 8,000 shares for a total of 384,000 options. Included in this grant were 400,000 non-qualified options with an initial vesting on March 12, 2008. From this grant 200,000 options were cancelled. In terms of the remaining 200,000 non-qualified options, 100,000 options are vested and exercisable.
  2. On February 2, 2009 Mr. Gasparini was granted an option to purchase 200,000 shares. These were performance options which vest based on various milestones. To date 50,000 shares are vested and exercisable, 50,000 shares have been cancelled and 100,000 shares are unvested.